Flucytosine (5-fluorocytosine, 5-FC) is a systemic antimycotic drug the maj
or toxicities of which are bone marrow depression and hepatotoxicity. The p
urpose of this observational and retrospective study was to assess a possib
le relationship between toxicity and 5-FC pharmacokinetics within a group o
f 53 intensive care unit patients, The presented results reveal that thromb
ocytopenia is associated with a decreased 5-FC clearance and that the throm
bocyte nadir is linearly related to the 5-FC clearance, Furthermore, patien
ts experiencing 5-FC levels exceeding 100 mg 5-FC/l were found to be at a h
igher risk of developing thrombocytopenia and hepatotoxicity as compared to
those not exceeding this level, Copyright (C) 2000 S. Karger AG, Basel.